The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS).
![Thumbnail](/bitstream/handle/11295/15497/Abstract.pdf.jpg?sequence=3&isAllowed=y)
View/ Open
Date
1990Author
Ogutu, EO.
Amayo, EO.
Okoth, F.
Lule, GN.
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
Forty one consecutive patients (24 males and 17 females) with AIDS had their blood assayed for HBsAg, anti-HBs and anti-HBc by Reversed Passive Haemagglutination (RPHA), Passive Haemagglutination (PHA) and Enzyme Linked Immunosorbent Assay (ELISA) techniques respectively. 5 (12.2%) were found positive for HBsAg. 10 (24.4%) for anti-HBs and 31 (75.6%) for anti-HBc. 32 (78%) out of 41 patients with AIDS had serological evidence of exposure to hepatitis B virus (HBV). The prevalence of HBsAg found in this study is not different from what has been found in the Kenyan community without AIDS, while that of anti-HBs is much lower than what has been reported in the general community
URI
http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/15497http://www.ncbi.nlm.nih.gov/pubmed/2390958
Citation
East Afr Med J.Publisher
Department of Medicine. College of Health Sciences. University of Nairobi
Collections
- Faculty of Health Sciences (FHS) [10385]